» Authors » Jens Kreuz

Jens Kreuz

Explore the profile of Jens Kreuz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 141
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goody P, Zimmer S, Ozturk C, Zimmer A, Kreuz J, Becher M, et al.
Int J Cardiol Heart Vasc . 2022 Jul; 41:101081. PMID: 35855974
Background: The diagnostic importance of three-dimensional (3D) speckle-tracking strain-imaging echocardiography in patients with acute myocarditis remains unclear. The aim of this study was to test the diagnostic performance of 3D-speckle-tracking...
2.
Kreuz J, Skowasch D, Kamrath P, Lorenzen H, Tiyerili V, Linhart M, et al.
Pacing Clin Electrophysiol . 2014 Sep; 38(1):71-6. PMID: 25196490
Background: Smoking is known as a relevant risk factor for severe cardiac morbidities and mortality. This study was initiated to explore the influence of smoking dosage and presence of chronic...
3.
Linhart M, Nielson A, Andrie R, Mittmann-Braun E, Stockigt F, Kreuz J, et al.
J Cardiovasc Electrophysiol . 2014 Apr; 25(8):859-865. PMID: 24724724
Introduction: Right phrenic nerve palsy (PNP) is a typical complication of cryoballoon ablation of the right-sided pulmonary veins (PVs). Phrenic nerve function can be monitored by palpating the abdomen during...
4.
Hoyer F, Henrich K, Kreuz J, Pizarro C, Schrickel J, Lickfett L, et al.
Cardiol J . 2013 Aug; 21(4):392-6. PMID: 23990193
Background: Obstructive sleep apnea (OSA) has been identified as associated with the onset and propagation of atrial fibrillation (AF) and predicts recurrences of AF after pulmonary vein isolation (PVI). Vice...
5.
Linhart M, Lewalter T, Mittmann-Braun E, Karbach N, Andrie R, Hammerstingl C, et al.
J Interv Card Electrophysiol . 2013 Jun; 38(2):107-14. PMID: 23793444
Purpose: Identification of reliable risk factors for recurrence of atrial fibrillation (AF) after pulmonary vein isolation (PVI) has important implications. Left atrial (LA) pressure is a largely observator-independent parameter that...
6.
Kreuz J, Skowasch D, Horlbeck F, Atzinger C, Schrickel J, Lorenzen H, et al.
Am J Cardiol . 2013 Feb; 111(9):1319-23. PMID: 23411108
Advanced heart failure (HF) is associated with severe sleep-disordered breathing (SDB). In addition, most patients with HF are treated with an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac...
7.
Horlbeck F, Mellert F, Kreuz J, Nickenig G, Schwab J
J Cardiovasc Electrophysiol . 2012 Aug; 23(12):1336-42. PMID: 22909190
Introduction: Implantable cardioverter-defibrillator (ICD) longevity is crucial for both patients and public health systems because it determines the number of surgical ICD replacements, which can generally be considered an additional...
8.
Pabst S, Hammerstingl C, Grau N, Kreuz J, Grohe C, Juergens U, et al.
Adv Exp Med Biol . 2012 Jul; 755:299-305. PMID: 22826080
Sarcoidosis is a systemic granulomatous disease with unknown etiology. Lungs and lymph nodes are commonly affected. Also, cases of pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH) are described. However,...
9.
Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, et al.
Clin Cardiol . 2012 Jun; 35(9):575-9. PMID: 22707222
Background: A growing number of patients with advanced heart failure fulfill a primary-prevention indication for an implantable cardioverter-defibrillator (ICD). This study seeks to identify new predictors of overall mortality in...
10.
Kreuz J, Horlbeck F, Linhart M, Mellert F, Fimmers R, Schrickel J, et al.
Europace . 2012 May; 14(11):1596-601. PMID: 22611058
Aims: The current study includes all consecutive patients with advanced heart failure and cardiac resynchronization therapy (CRT) with an implantable cardioverter defibrillator (ICD) over a 10-year period in a tertiary...